Albert D Mason Inc. Has $424,000 Holdings in CVS Health Co. (NYSE:CVS)

Albert D Mason Inc. trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 38.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,435 shares of the pharmacy operator’s stock after selling 5,990 shares during the period. Albert D Mason Inc.’s holdings in CVS Health were worth $424,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Avanza Fonder AB bought a new position in shares of CVS Health in the 4th quarter valued at approximately $4,745,000. Sterling Financial Group Inc. grew its holdings in CVS Health by 16.4% during the fourth quarter. Sterling Financial Group Inc. now owns 15,363 shares of the pharmacy operator’s stock valued at $690,000 after purchasing an additional 2,169 shares during the last quarter. Empirical Asset Management LLC raised its position in shares of CVS Health by 816.4% in the fourth quarter. Empirical Asset Management LLC now owns 36,885 shares of the pharmacy operator’s stock valued at $1,656,000 after purchasing an additional 32,860 shares during the period. Dixon Mitchell Investment Counsel Inc. lifted its stake in shares of CVS Health by 38.7% in the fourth quarter. Dixon Mitchell Investment Counsel Inc. now owns 1,168 shares of the pharmacy operator’s stock worth $52,000 after buying an additional 326 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. grew its stake in CVS Health by 16.6% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 9,101 shares of the pharmacy operator’s stock valued at $409,000 after buying an additional 1,296 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Up 1.5 %

Shares of CVS opened at $52.72 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a 50-day moving average price of $51.39 and a two-hundred day moving average price of $56.36. The stock has a market cap of $66.35 billion, a price-to-earnings ratio of 13.38, a P/E/G ratio of 0.72 and a beta of 0.59. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 5.05%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

A number of research firms have weighed in on CVS. Piper Sandler cut their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.